16 Jan 2015

Neuropore and UCB enter into world-wide collaboration and agreement

Read More
13 Jan 2015

UCB’s new CEO Jean-Christophe Tellier introduces executive team

Read More
9 Jan 2015

Update of transparency notification UCB SA/NV

Read More
8 Jan 2015

Dermira and UCB announce start of Phase 3 program for CIMZIA® (certolizumab pegol) in psoriasis

Read More
6 Jan 2015

Acquisition of own shares

Read More
16 Dec 2014

UCB, Advent International and Avista Capital Partners mutually agree to terminate acquisition agreement for Kremers Urban

Read More
8 Dec 2014

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy

Read More
3 Dec 2014

UCB reinforces its leadership in epilepsy at the 2014 Annual Meeting of the American Epilepsy Society (AES)

Read More
28 Nov 2014

UCB and Daiichi Sankyo partner to bring Lacosamide to people living with epilepsy in Japan

Read More
14 Nov 2014

UCB shows strong scientific presence at leading rheumatology meeting

Read More
Subscribe to